Introduction
Bergmann's pioneering work on novel nucleosides, e.g., spongouridine (1) and spongothymidine (2), in the early 1950s led to development of an anti-cancer drug, Ara-C (cytarabine; 3) and antiviral drug, Ara-A (vidarabine; 4), both of which are still in clinical use.' There is no doubt that this event played a crucial role in the birth of a new research area, Marine Natural Products Chemistry in the early 1970s. 
Antimicrobial Compounds
In 1984 we isolated a unique cyclic tetradecapeptide named discodermin A (5) as an antimicorbial constituent of the marine sponge Discodermia kiiensis.4 This peptide contains a large portion of D-amino acids as well as such unusual amino acids as tert-leucine, cysteic acid, and sarcosine, the last of which forms an ester linkage with Thr. In addition to antimicrobial activity, discodermin A shows a variety of biological activities including inhibition of phospholipase A2 (PLA2), HIV reverse transcriptase, and chitinase as well as of okadaic acid-induced cancer promotion.5 Recently, its permeabilizing effect on the plasma membrane was reported, possibly by interacting with membrane phospholipids.6 Discodermin A happened to be the first bioactive sponge peptide, and thereafter a large number of bioactive peptides have been isolated from marine sponges.5,7
The unusual macrolides of the kabiramide/mycalolide class are highly antifungal as well as cytotoxic. Kabiramide C (6) isolated from egg masses of a nudibranch of the genus Hexabranchus (Mollusca; Opisthobranchia) is composed of an unprecedented trisoxazole-containing macrolide and a polyketide side chain.8 Later, mycalolide. B (7), a macrolide of essentially the same framework, was isolated from marine sponges of the genus Mycale.9 Although these macrolides were very potent in antifungal and cytotoxicity tests, they are too toxic for development of drugs. The mode of action study disclosed that they bind to G-actin in a molar ratio of 1 : 1, thereby not only inhibiting actin polymerization but also inducing depolymerization of actin filaments.10 Quite recently, the crystal structure of the complex of kabiramide C and G-actin was elucidated; the hydrophobic polyketide side chain, especially the vinylformamide group plays an important role in binding to the actin molecule." Surprisingly, this macrolide mimics the action of gelsolin, an actin-binding In contrast to the spindle toxins mentioned above, some marine natural products stabilize microtubule filaments, thereby inhibiting proliferation of tumor cells.20 Eleutherobin (17) first isolated from an Australian soft coral Eleutherobia sp. is a unique diterpene glycoside. 23 Recently, we isolated from the soft coral Bellonella albiflora a diterpene of the same class, (Z)-sarcodictyin A (18), which inhibits the growth of HeLa cells with an IC50 value of 90 ng/mL.24 Discodermolide (19), a polyketide discovered from the deep-sea sponge Discodermia dissoluta, showed promising antitumor activity and is under phase I clinical trials.'n' Laurimalide (20) , a macrolide metabolite of the marine sponges Cacospongia mycofijiensis and Hyattella sp. also stabilizes microtubules.26
The marine sponge Theonella swinhoei collected from Hachijo-jima Island is quite productive, containing a variety of metabolites with unusual structures and potent bioactivities, among which theopederins A-E [theopederin A (21)] showed promising antitumor activity (IC50 values against P388 of 0.05-9.0 ng/ml).27 Unfortunately, their low yields prevented further in vivo testings. More interestingly, they are quite similar to pederin (22) , a venom of blister beetles Paederus spp.; recently, genes involved in pederin biosynthesis were cloned from a symbiotic bacterium.28 It is therefore likely that theopederins are also synthesized by symbiotic microbes.
Calyculin A (23) is a unique polyketide/non-ribosomal peptide metabolite derived from the marine sponge Discodermia calyx.29 It was originally isolated as an antitumor metabolite (IC50 value against L1210 of 0.74 ng/mL), and later its potent cancer promoter activity, followed by its selective inhibition of protein phosphatases 1 and 2A were discovered.3° Further attempts at isolation of new calyculins from the same sponge resulted in the discovery of 9 new derivatives.31 Particularly interesting is hemicalyculin A (24) which is a truncated calyculin derivative. Interestingly, it inhibits protein phosphatases 1 and 2A as strongly as does calyculin A, but its cytotoxicity against P388 cells is much less than that of the parent compound (IC50 values of 450 and 0.17 ng/ml against P388 cells, respectively). Perhaps, inhibition of protein phosphatases can be separated from cytotoxicity. Chemical transformation of calyculin A also provided important information of the structure-activity relationships; significantly, C9/C25 calyculin (25) is no longer active in both cytotoxic and enzyme inhibition tests.31e Finally, X-ray diffraction of the PP1 y/calyculin A complex clearly disclosed the mode of binding of calyculin A to the enzyme (Fig. 1) ; calyculin A binds to the catalytic center of the enzyme, in which the phosphate group, tetraene portion, and 13-hydroxyl group play crucial roles.32 This mode of binding is very similar to those of microcystin-LR33 and okadaic acid34 It should be noted that the free calyculin A adopts a "holded" conformation, whereas the bound form is in the extended conformation.
In the screening for cytotoxic activity, the tunicate Ritterella tokioka collected off the Izu Peninsula showed potent activity. Bioassay-guided fractionation afforded 26 unusual dimeric steroids named ritterazine A-Z, among which ritterazine B (26) was the most potent (IC50 against P388, 0.15 ng/ml). 35 Closely related compounds named cephalostatins were isolated from the phylogenetically remote, hemichodate Cephalodiscus gilchristi.36 They are surprisingly potent; cephalostatin 1 (27) showed IC50 values of 10-4-10-6 jug/m1 against P388 cells. These unusual dimeric steroids are most likely synthesized by symbiotic microorganisms.
Shishijimicin A (28) is an unprecedented p carboline containing endiyne discovered from the tunicate Didemnum proliferum collected in southern Japan.37 Although its structure is similar to that of namenamicin (29) isolated from a Fijian tunicate Polysyncraton lithostrotum,38 its cytotoxicity is much more potent than that of 29 (IC50 against HeLa cells: 1.8 vs. 34 pg/ml). Perhaps, symbiotic microbes are involved in the synthesis of these enediynes.
Enzyme Inhibitors
Overexpression or hyperactivation of cetain enzymes are linked to human diseases, thus indicating their inhibitors to be potential drugs. For more than 20 years we have been trying to discover inhibitors of such enzymes; perhaps the most interesting is cyclotheonamide A (30) isolated from T. swinhoei, which contains two new amino acids, a-ketohomoarginine (kArg) and vinylogous tyrosine (vTyr).39 It inhibits both thrombin and trypsin at nM levels. The crystal structure of a complex between human a-thrombin and cyclotheonamide A clearly showed that 30 binds to the catalytic center of thrombin; kArg forms a hemiacetal linkage with Ser-195, one of the catalytic triad. 40 The vTyr residue also plays an important role in stabilizing the binding of 30 to the enzyme. The importance of the kArg residue was evident from the structure-activity relationship study; pseudocyclotheonamide A (31), in which the kArg residue is cyclized, inhibits thrombin very weakly.41 Theonella mirabilis collected in the Tokara Archipelago afforded two linear peptides that inhibit cathepsin B, among which miraziridine A (32) has an unusual structure, containing a number of new amino acids,42 though its activity is not impressive. Quite recently, the total synthesis of 32 has been accomplished.43
is linked to diabetes and viral diseases. In fact, some a-glucosidase inhibitors are in clinical use. 44 We have reported several inhibitors from marine sponges45; the most recent example is schulzeines A-C [schulzeine A (33)], the rare isoquinoline alkaloids isolated from the marine sponge Penares schulzei.46 33 inhibits a-glucosidase with an IC50 value of 48 nM, while its desulfated derivative still retains the activity (IC50 value of 2.5 juM). Schulzeines also inhibit viral neuraminidase (IC50 60 4uM).
In 90% human tumor cells is expressed telomerase which adds telomeres onto the 3"-end of chromosomes.47 Thus, telomerase is a good target for cancer chemotherapeutics. In our screening for telomerase inhibitors, the marine sponge Dictyodendrilla verongiformis collected in southern Japan showed potent activity, and bioassay-guided isolation furnished four novel alkaloids named dictyodendrins A-D{dic-tyodendrin A (34)].48 They inhibited telomerase completely at a concentration of 50 dug/mi. Finally, ageladine A (35) is an antiangiogenic matrix metalloproteinase (MMP) inhibitor isolated from the marine sponge Agelas nakarnurai.49 It shows a broad spectrum of MMP inhibition (IC50 values of 0.33-2.0 jug/me. More importantly, ageladine A inhibits cell migration using bovine aortic cells.
Receptor and Channel Antagonists
Over-expression of receptors and channels also results in diseases, and their antagonists are potential drug leads. For example, over-expression of interleukin 6 receptors often leads to cancer, inflammation and other disorders. Erylusamine E (36), an unusual liposaccharide isolated from the marine sponge Erylus placenta inhibits binding of IL-6 to its receptors with an IC50 value of 17 pg/m1.5° Aurantoside A (37), a polyene tetramic acid glycoside isolated from T. swin- 
